CSI Market
Sign In | Register

Neuropathix (TYGS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TYGS Annual Balance Sheets →
From Neuropathix through Mar 31 2021, shifts in Mar 31 2022's assets and liabilities provide insight into the company's capital structure and financial stability.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2022)
(Dec 31 2021) (Sep 30 2021) (Jun 30 2021) (Mar 31 2021)
Assets
Cash & cash equivalent0.10
Security Deposit0.02
Cash & Short-term Investments0.00
Other Receivables0.00
Prepaid Expense, Current AS0.01
Total Current Assets0.13
Equipment/Property/Plant Net0.06
Other Assets, Noncurrent0.20
Operating Lease Right Of Use Asset0.20
Operating Lease Right Of Use Asset0.20
Total Assets0.39
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.82
Accrued Liabilities, Current AC0.52
Derivative Liability, Current DE0.70
Short-term Debt0.91
Other Liabilities, Current0.64
Deferred Revenue, Current DE0.00
Total Current Liabilities3.60
Long-term debt0.38
Capital Lease Obligations, Noncurrent LO0.02
Convertible Debt LO0.15
Total Long-term Debt0.54
Derivative Liability, Noncurrent DE1.07
Deferred Tax Liabilities, Deferred Expense, Other Capitalized Costs0.38
Other liabilities, Noncurrent0.04
Operating Lease Liability Current0.11
Operating Lease Liability Noncurrent0.08
Total Liabilities5.64
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock12.93
Retained Earnings / Accumulated Deficit-18.19
Other Equity0.00
Common Stockholder's Equity-5.25
Total Stockholder's Equity-5.25
Liabilities & Stockholder's Equity0.39
4 historic quarters locked

Sign in to unlock the full Neuropathix balance sheet history.

Sign In Create Free Account

About Neuropathix Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001607062-22-000388

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.